SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nova Anchora Announces $23 Million Financing for Therapy Development

Nova Anchora said the financing will advance its topical collagen VII therapy for dystrophic epidermolysis bullosa. The financing was led by Viking Global Investors alongside venture philanthropy investors.

Related stories